Bolt Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $159.8M
Liabilities Breakdown FY2023
Total Liabilities: $47.0M
Asset Breakdown
Total Assets: $159.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.8M | 6.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.0M | 3.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $144.0M | 90.1% |
Liabilities Breakdown
Total Liabilities: $47.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 6.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $44.1M | 93.7% |